1. Home
  2. ACLX

as 12-06-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Founded: 2015 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 5.3B IPO Year: 2022
Target Price: $103.67 AVG Volume (30 days): 466.2K
Analyst Decision: Strong Buy Number of Analysts: 14
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.77 EPS Growth: N/A
52 Week Low/High: $46.42 - $107.37 Next Earning Date: 11-07-2024
Revenue: $155,818,000 Revenue Growth: 230.33%
Revenue Growth (this year): 10.41% Revenue Growth (next year): -9.43%

ACLX Daily Stock ML Predictions

Stock Insider Trading Activity of Arcellx Inc. (ACLX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Patel Kavita ACLX Director Dec 3 '24 Sell $92.02 1,500 $137,817.72 0
Gilson Michelle ACLX CHIEF FINANCIAL OFFICER Nov 15 '24 Sell $90.93 1,761 $156,508.43 100
Patel Kavita ACLX Director Nov 12 '24 Sell $106.33 1,500 $159,495.00 0
Gilson Michelle ACLX CHIEF FINANCIAL OFFICER Nov 8 '24 Sell $101.29 12,354 $1,242,170.45 100
Patel Kavita ACLX Director Nov 7 '24 Sell $102.92 57,479 $5,971,808.80 0
Patel Kavita ACLX Director Oct 22 '24 Sell $89.69 1,500 $134,535.00 0
Patel Kavita ACLX Director Oct 1 '24 Sell $82.24 1,500 $123,360.00 0
Gilson Michelle ACLX CHIEF FINANCIAL OFFICER Sep 17 '24 Sell $77.69 15,000 $1,165,879.57 100
Patel Kavita ACLX Director Sep 10 '24 Sell $74.41 1,500 $111,615.00 0

Share on Social Networks: